Can the described wound‑healing inflammatory cascade be presented as a flow chart?

Can the Wound-Healing Inflammatory Cascade Be Presented as a Flow Chart?

Yes, the wound-healing inflammatory cascade can absolutely be presented as a flow chart, and in fact, Figure 5 from the 2020 Small journal guideline already provides exactly this—a time-resolved visual representation of the sequential and overlapping phases of inflammation initiation and resolution 1.

The Flow Chart Structure

The inflammatory cascade in wound healing follows a temporal progression that can be algorithmically mapped:

Phase 1: Hemostasis & Acute Inflammation (Hours 0-72)

Initial Trigger:

• Tissue injury → Epithelial cell activation
• Release of proinflammatory cytokines: TNF-α, IL-8, IL-6 1
• Platelet degranulation releases PDGF (stimulates neutrophil, monocyte, macrophage, and fibroblast chemotaxis) 2
• Concurrent release of TGF-β and VEGF from platelets 2

Cellular Recruitment:

• Neutrophils infiltrate first (facilitated by IL-8, TNF-α)
• Monocytes follow (recruited by MCP-1 and GM-CSF) 1

Destructive Phase:

• Neutrophils and monocytes release:
  • ROS and reactive nitrogen species (RNS)
  • Nitric oxide (NO)
  • Hydrolytic enzymes
  • Additional proinflammatory cytokines (IL-1) 1

Phase 2: M1 Macrophage Polarization (Days 1-3)

Differentiation Trigger:

• Monocytes exposed to LPS, TNF-α, and IFN-γ
• Differentiate into classically activated macrophages (M1) 1
• Innate lymphoid cells contribute to M1 differentiation 1

M1 Functions:

• Sustained ROS production
• Pathogen eradication
• Induce T cell polarization to Th1 phenotype (establishing long-term inflammatory response with adaptive immunity) 1

Phase 3: Resolution & M2 Transition (Days 3-7)

Anti-inflammatory Switch:

• TGF-β and IL-10 production increases 1
• Macrophages downregulate inflammatory mediators
• Transition to alternatively activated macrophages (M2) 1

M2 Functions:

• Upregulated phagocytic capacity
• Clear cellular debris from neutrophil attack
• Produce anti-inflammatory cytokines: IL-10, IL-25, IL-33, TSLP 1

Phase 4: Proliferation & Tissue Remodeling (Days 7+)

Growth Factor Release:

• FGF (fibroblast growth factor): Cell proliferation and angiogenesis 1
• VEGF: Angiogenesis and vascular remodeling 1, 2
• EGF: Epithelial cell proliferation, differentiation, and survival 1

Tissue Reconstitution:

• Extracellular matrix reorganization
• Vascular maturation
• Can take months to years for complete remodeling 1

Critical Flow Chart Elements to Include

Time-Resolved Axis: The horizontal axis should represent time (hours to months) to show overlapping phases 1.

Cellular Components:

• Epithelial cells → Neutrophils → Monocytes → M1 macrophages → M2 macrophages → Fibroblasts → Endothelial cells

Molecular Mediators (in temporal order):

• Early (0-24h): TNF-α, IL-8, IL-6, PDGF, TGF-β, VEGF
• Mid (1-3 days): IL-1, ROS, RNS, NO, LPS, IFN-γ, MCP-1, GM-CSF
• Late (3-7 days): IL-10, TGF-β, IL-25, IL-33, TSLP
• Remodeling (7+ days): FGF, VEGF, EGF 1, 2, 1

Common Pitfalls in Flow Chart Design

Avoid oversimplification: The phases are overlapping, not discrete 1. Your flow chart must show temporal overlap between inflammation, proliferation, and remodeling.

Context matters for interpretation: Brief TNF-α or IL-8 elevation represents normal fluctuation, while persistent inflammatory markers advancing through regular steps raises concern 1. The flow chart should distinguish transient vs. sustained responses.

Chronic wound deviation: In chronic wounds (70% of all wounds), the inflammatory phase becomes prolonged and arrested, creating bacterial infiltration risk 3. Consider adding a branch showing pathological deviation from normal cascade.

Practical Implementation

The flow chart should be bidirectional where applicable—showing positive feedback loops (e.g., M1 macrophages inducing Th1 cells that perpetuate inflammation) and negative feedback (TGF-β/IL-10 suppressing inflammatory mediators) 1.

Include decision points:

• Is inflammation resolving by day 3-5? → Proceed to M2 transition
• Persistent M1 activity beyond day 7? → Risk of chronic wound formation
• Adequate growth factor production by day 7-14? → Successful remodeling phase

The existing Figure 5 from the Small journal guideline 1 serves as the gold standard template, depicting cellular entities on the vertical axis and time progression horizontally, with molecular mediators annotated at their respective temporal windows.